FI941876L - Uusia 2,6-disubstituoituja puriinijohdannaisia - Google Patents

Uusia 2,6-disubstituoituja puriinijohdannaisia Download PDF

Info

Publication number
FI941876L
FI941876L FI941876A FI941876A FI941876L FI 941876 L FI941876 L FI 941876L FI 941876 A FI941876 A FI 941876A FI 941876 A FI941876 A FI 941876A FI 941876 L FI941876 L FI 941876L
Authority
FI
Finland
Prior art keywords
new
purine derivatives
disubstituted purine
disubstituted
derivatives
Prior art date
Application number
FI941876A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941876A7 (fi
FI941876A0 (fi
Inventor
Lars Jacob Stray Knutsen
Jesper Lau
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI941876A0 publication Critical patent/FI941876A0/fi
Publication of FI941876A7 publication Critical patent/FI941876A7/fi
Publication of FI941876L publication Critical patent/FI941876L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI941876A 1991-10-24 1992-10-21 Uusia 2,6-disubstituoituja puriinijohdannaisia FI941876L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK9100324 1991-10-24
PCT/DK1992/000307 WO1993008206A1 (en) 1991-10-24 1992-10-21 Novel 2,6-disubstituted purine derivatives

Publications (3)

Publication Number Publication Date
FI941876A0 FI941876A0 (fi) 1994-04-22
FI941876A7 FI941876A7 (fi) 1994-06-22
FI941876L true FI941876L (fi) 1994-06-22

Family

ID=8153695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941876A FI941876L (fi) 1991-10-24 1992-10-21 Uusia 2,6-disubstituoituja puriinijohdannaisia

Country Status (11)

Country Link
US (2) US5432164A (OSRAM)
EP (1) EP0609375A1 (OSRAM)
JP (1) JPH07500586A (OSRAM)
AU (1) AU657374B2 (OSRAM)
CA (1) CA2121844A1 (OSRAM)
FI (1) FI941876L (OSRAM)
IL (1) IL103513A (OSRAM)
NO (1) NO300461B1 (OSRAM)
NZ (1) NZ244875A (OSRAM)
WO (1) WO1993008206A1 (OSRAM)
ZA (1) ZA928222B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
WO1997033590A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
RU2172320C2 (ru) * 1996-08-27 2001-08-20 Си Ви Терапьютикс, Инк. Производные аденозина, фармацевтическая композиция и способ коррекции электрических нарушений в сердце млекопитающего
AU4377397A (en) * 1996-10-14 1998-05-11 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
US6175004B1 (en) * 1998-09-01 2001-01-16 Isis Pharmaceuticals, Inc. Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
KR20050097971A (ko) * 2003-02-03 2005-10-10 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ₁아데노신 수용체의 부분 및 전 작용제
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
WO2007107598A1 (en) 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
WO2015094759A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using an active agent comprising at least two functional groups selected from: -c(oh)- and -c(=o)oh
EP3297730A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Method of shaping keratin fibres
EP3297731A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Shaping keratin fibres using arabinose and ethylene carbonate
KR20250121114A (ko) 2022-12-16 2025-08-11 아스트라제네카 아베 2,6,9-삼치환된 퓨린

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE768925A (fr) * 1970-06-30 1971-11-03 Takeda Chemical Industries Ltd Derives d'adenosine et procede de preparation
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
CA2028002A1 (en) * 1989-10-19 1991-04-20 Daniel P. Becker Method of treating gastrointestinal motility disorders
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives

Also Published As

Publication number Publication date
US5432164A (en) 1995-07-11
WO1993008206A1 (en) 1993-04-29
CA2121844A1 (en) 1993-04-29
EP0609375A1 (en) 1994-08-10
US5578582A (en) 1996-11-26
NO300461B1 (no) 1997-06-02
FI941876A7 (fi) 1994-06-22
IL103513A (en) 1996-09-12
IL103513A0 (en) 1993-03-15
AU657374B2 (en) 1995-03-09
NO941477L (OSRAM) 1994-06-23
NZ244875A (en) 1995-04-27
AU2916092A (en) 1993-05-21
FI941876A0 (fi) 1994-04-22
ZA928222B (en) 1994-04-25
JPH07500586A (ja) 1995-01-19
NO941477D0 (no) 1994-04-22

Similar Documents

Publication Publication Date Title
NL300250I1 (nl) Chinuclidinederivaten.
FI934919L (fi) Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning
DK0680488T3 (da) 2,6-Diaminopurinderivater
FI923314L (fi) Substituerade cyklopropylamino-1,3,5-triaziner
FI924160A7 (fi) Benzanilidderivat
FI935726A7 (fi) Atsanorbornaanijohdannaisia
NO922182L (no) Krystallinske oksatiolan-derivater
BR9106540A (pt) 1,4-diamino-2,3-didroxibutanos
FI941876A7 (fi) Uusia 2,6-disubstituoituja puriinijohdannaisia
FI930429A0 (fi) Nya 1,4-dihyropyridinderivat
NO912804L (no) Purinderivater.
FI920394L (fi) 3-kinuklidinderivat.
FI925258A7 (fi) Foerfarande foer framstaellning av 2-substituerade 4,6-dialkoxipyrimidiner
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate
FI901277A7 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenyleeni PG1z-johdannaisia
FI925441A0 (fi) 1,4-diamino-2,3-dihydroxibutaner
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
FI941909A0 (fi) 2,6-disubstituoidut 4-kinolyylidihydropyridiinit
FI923542L (fi) Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner
FI935657L (fi) Foerfarande foer framstaellning av 3,4-dihydroxi-5-nitrobensaldehyd
FI923201A7 (fi) 3,4-dehydropiperidiinijohdannaisia
MX9202291A (es) Derivados carboxamido-(3,2n)-carbociclico-2-amino tetralinas.
FI921760L (fi) Viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner med foerbaettrad doserbarhet
ATE151751T1 (de) Karboxamido-(1,2n)-karbocyclo-2- aminotetralinderivate
BG97241A (bg) Триазолпиримидин производни

Legal Events

Date Code Title Description
FD Application lapsed